Pregled bibliografske jedinice broj: 224120
Superior clinical, endoscopic and histologic efficacy and tolerability of pantoprazole compared with ranitidine and omeprazole in patinets with gastro-esophageal reflux disease (GORD)
Superior clinical, endoscopic and histologic efficacy and tolerability of pantoprazole compared with ranitidine and omeprazole in patinets with gastro-esophageal reflux disease (GORD) // Gastroenterology / Digestive Disease Week (ur.).
New Orleans (LA), Sjedinjene Američke Države: American Gastroenterological Association, 2004. str. A-341 (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 224120 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Superior clinical, endoscopic and histologic efficacy and tolerability of pantoprazole compared with ranitidine and omeprazole in patinets with gastro-esophageal reflux disease (GORD)
Autori
Pulanić, Roland ; Premužić, Marina ; Brkić, Tomislav ; Opačić, Milorad ; Jokić-Begić, Nataša
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Gastroenterology
/ Digestive Disease Week - : American Gastroenterological Association, 2004, A-341
Skup
Digestive Disease Week
Mjesto i datum
New Orleans (LA), Sjedinjene Američke Države, 15.05.2004. - 20.05.2004
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
gastroesophageal reflux disease; PPI therapy
Sažetak
Pharmacologycal, acid-suppressing therapy with standard doses of PPI has markedly improved the outcome of GORD. Pantoprasole has significantly better resultsthan omeprasole, it is highly effectice and well tolerated in the treatment of GORD
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
